Rheumatology

BENLYSTA

BENLYSTA (belimumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells
Infusion or injection therapy referral
What it treats Systemic Lupus
Prescribed by Rheumatologists
How it’s administered Intravenous (IV) infusion
or subcutaneous injection
Frequency Every two weeks for three doses,
then every four weeks
Length of treatment About an hour

About This Therapy

BENLYSTA (belimumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage. Specifically, it is a B-lymphocyte stimulator. BENLYSTA is used together with other lupus medicines to treat active systemic lupus erythematosus (SLE).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

BENLYSTA REFERRAL FORM

BENLYSTA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for BENLYSTA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.